GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Advanced Enzyme Technologies Ltd

Advanced Enzyme Tech Completes 1.22% Stake Acquisition in JC Biotech

M&A ▲ Positive Development LOW RISK
📅 Filed on BSE: 19 Nov 2026, 02:49 PM IST  ·  BSE ID: 130875a2-acbf-4180-8757-975dfe24b606
View Original BSE Filing (PDF)
💡
In Simple Terms
The company bought more shares in its subsidiary, JC Biotech, increasing its ownership from 95.72% to 96.94%.
🤖 AI Summary
  • Advanced Enzyme Technologies completed acquisition of additional 1.22% stake in JC Biotech Private Limited.
  • The company purchased 2,53,297 Equity Shares for a consideration of ₹ 22.80 million.
  • Total shareholding in JC Biotech Private Limited increased from 95.72% to 96.94% effective November 18, 2026.
  • The acquisition consideration per equity share was ₹ 90.
  • Advanced Enzyme Technologies is acquiring the remaining 3.06% stake to make JC Biotech a Wholly Owned Subsidiary.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Acquired Stake
1.22%
Equity Shares Purchased
2,53,297 Equity Shares
Consideration Paid
₹ 22.80 million
Price Per Equity Share
₹ 90 per Equity Share
New Shareholding in JC Biotech
96.94%
Previous Shareholding in JC Biotech
95.72%
Remaining Stake to Acquire
3.06%
🏢 How This Affects the Company
📈
Business Impact
Increasing stake in JC Biotech Private Limited strengthens Advanced Enzyme Technologies' control over the subsidiary's operations and strategic direction. Full ownership would streamline integration and decision-making for the enzyme business.
💰
Financial Impact
The acquisition involved a cash outflow of ₹ 22.80 million. Full ownership of JC Biotech Private Limited would lead to 100% consolidation of its financials.
⚙️
Operational Impact
Increased ownership enables greater operational synergy and integration with JC Biotech Private Limited's activities, potentially optimizing resource allocation and efficiency.
⚠️
Risk Impact
Increased ownership reduces the risk associated with minority interests in the subsidiary, granting Advanced Enzyme Technologies full control over its assets and liabilities.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this announcement.
👤
Who Is Affected
Existing shareholders of Advanced Enzyme Technologies Ltd are affected by the cash outflow of ₹ 22.80 million and the increased ownership in the subsidiary.
🔍
Management Signal
Management's decision indicates a strategy to consolidate control over key subsidiaries and achieve wholly-owned status for greater operational and financial integration.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Announcement regarding the acquisition of the remaining 3.06% stake in JC Biotech.
Advanced Enzyme Technologies' next financial results for impact of this acquisition.
Any further updates on the operational integration of JC Biotech Private Limited.
LOW RISK The filing confirms completion of an announced acquisition, reducing prior uncertainty.
💡 Investor Takeaway
Advanced Enzyme Technologies Ltd completed the acquisition of an additional 1.22% stake in JC Biotech Private Limited for ₹ 22.80 million, raising its shareholding from 95.72% to 96.94%. The company plans to acquire the remaining 3.06% for full ownership.
⚖️ Strengths & Concerns

✅ Positives

  • Shareholding in JC Biotech Private Limited increased to 96.94%, nearing full ownership and simplifying governance.
  • Consideration for the additional 1.22% stake was ₹ 22.80 million, a defined cost for increased control.
❓ Frequently Asked Questions
What additional stake did Advanced Enzyme Technologies acquire in JC Biotech Private Limited?
Advanced Enzyme Technologies Ltd acquired an additional 1.22% stake in JC Biotech Private Limited, increasing its total shareholding.
What was the consideration for the additional stake in JC Biotech Private Limited?
The consideration for the additional 1.22% stake in JC Biotech Private Limited was ₹ 22.80 million for 2,53,297 Equity Shares.
What is Advanced Enzyme Technologies' new shareholding percentage in JC Biotech Private Limited?
The company's shareholding in JC Biotech Private Limited has increased from 95.72% to 96.94% of the paid-up share capital.
What is the next step for Advanced Enzyme Technologies regarding JC Biotech Private Limited?
The company is in the process of acquiring the remaining 3.06% equity stake, which will make JC Biotech Private Limited a Wholly Owned Subsidiary.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses free when you sign up

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.

Live IPO, GMP and market updates on Telegram

IPO open and close dates, grey market premium moves, subscription figures, allotment and listing days, and the market updates worth knowing about, posted on the channel as they happen.

Join the channel